Clarus Therapeutics Inc. announced positive results of an open-label, multi-center safety and efficacy analysis following two years of Jatenzo (testosterone undecanoate) oral capsules use in hypogonadal men.
Testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests (see section 4.4).